Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES, Ferrer A, Mangaonkar AA, Khan SP, Kohorst MA, Joshi AY, Hogan WJ, Olteanu H, Moyer AM, Al-Kali A, Tefferi A, Chen D, Wudhikarn K, Go R, Viswanatha D, He R, Ketterling R, Nguyen PL, Oliveira JL, Gangat N, Lasho T, Patnaik MM. Martin ES, et al. Among authors: go r. Am J Hematol. 2021 Nov 1;96(11):1450-1460. doi: 10.1002/ajh.26321. Epub 2021 Aug 27. Am J Hematol. 2021. PMID: 34390506 Free article.
22-year-old woman with severe microcytic anemia.
Shoho AR, Go RS, Tefferi A. Shoho AR, et al. Among authors: go rs. Mayo Clin Proc. 2000 Aug;75(8):861-4. doi: 10.4065/75.8.861. Mayo Clin Proc. 2000. PMID: 10943245 No abstract available.
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust SR, Leung N, Kyle RA, Russell SJ, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Rajkumar SV, Dispenzieri A. Kourelis TV, et al. Among authors: go r. Am J Hematol. 2014 Mar;89(3):302-5. doi: 10.1002/ajh.23634. Epub 2014 Feb 18. Am J Hematol. 2014. PMID: 24265187 Free article.
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.
Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A. Dispenzieri A, et al. Among authors: go rs. Am J Hematol. 2015 Jun;90(6):524-8. doi: 10.1002/ajh.24001. Epub 2015 Apr 2. Am J Hematol. 2015. PMID: 25753178 Free article. Clinical Trial.
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
Majithia N, Vincent Rajkumar S, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK. Majithia N, et al. Among authors: go rs. Am J Hematol. 2015 Nov;90(11):981-5. doi: 10.1002/ajh.24131. Epub 2015 Oct 6. Am J Hematol. 2015. PMID: 26214732 Free PMC article.
883 results